Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen (Q64389694)
Jump to navigation
Jump to search
scientific article published on 01 August 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen |
scientific article published on 01 August 1994 |
Statements
Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen (English)
F Leteurtre
G Kohlhagen
K D Paull